Table 2.
Dosage regimens proposed in this study and further explored in the simulations.
No | Dosing scheme |
---|---|
new1 | Day1: 500 mg x2 Day 2 and afterwards: 250 mg x2 |
new2 | Day 1: 500 mg x2 Day 2: 500 mg x2 Day 3 and afterwards: 250 mg x2 |
new3 | Day 1: 500 mg + 500 mg + 250 mg (with 8 h intervals) Day 2: 500 mg x2 Day 3: 250 mg x2 |
new4 | Day 1: 500 mg + 500 mg + 250 mg (with 8 h intervals) Day 2: 500 mg x2 Day 3: 500 mg x2 Day 4 and afterwards: 250 mg x3 |